Outcome after bevacizumab clinical trial therapy among recurrent grade III malignant glioma patients.
J Neurooncol
; 107(1): 213-21, 2012 Mar.
Article
in En
| MEDLINE
| ID: mdl-21997879
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Brain Neoplasms
/
Salvage Therapy
/
Angiogenesis Inhibitors
/
Antibodies, Monoclonal, Humanized
/
Glioma
Type of study:
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Limits:
Adult
/
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
J Neurooncol
Year:
2012
Document type:
Article
Affiliation country:
United States
Country of publication:
United States